An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy

Sevindik, Omur GokmenOzkurt, Zubeyde NurBoga, CanBesisik, Sevgi KalayogluIpek, YildizGeduk, AyferHarmandali, Aybuke2024-06-122024-06-1220210006-49711528-0020https://doi.org/10.1182/blood-2021-150175https://hdl.handle.net/20.500.14551/2590663rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 11-14, 2021 -- Atlanta, GA[Abstract Not Available]en10.1182/blood-2021-150175info:eu-repo/semantics/openAccess[No Keywords]An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of TherapyConference Object138Q1WOS:000835740102199